Results 101 to 110 of about 33,530 (249)

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo   +4 more
wiley   +1 more source

Enigma of pulmonary hypertension; echocardiography in the crossroads

open access: yesRespiratory Medicine Case Reports, 2020
Background: Pulmonary hypertension (PH) with its myriad presentations provides a challenge in its diagnosis and management. Recent WHO classification of pulmonary hypertension as defined at the 5th World Symposium held in Nice, France in 2013 tries to ...
Debasish Roychoudhury   +3 more
doaj   +1 more source

Prevalence of undiagnosed chronic thromboembolic pulmonary hypertension after pulmonary embolism

open access: yes, 2014
Chronic thromboembolic pulmonary hypertension is associated with adverse prognosis. Early diagnosis is important to better identify patients who would benefit from a well established therapeutic strategy.
C. Piccinino   +7 more
core   +1 more source

Is There a Difference in Occurrence of Complications Between Adults With Hemoglobin SS and Hemoglobin SC Disease: An Extended Systematic Review

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Sickle cell disease (SCD) is characterized by both acute and chronic complications. The clinical manifestation of these complications differs between genotypes. Given the large amount of research already published, this systematic review aims to offer a complete overview of types of sickle cell complications between adults in the most common ...
Martijn van der Meer   +3 more
wiley   +1 more source

Performing Large‐Scale Genetic Analysis in the Bleeding Disorders Community

open access: yesHaemophilia, EarlyView.
ABSTRACT Inherited bleeding disorders encompass a diverse group of conditions caused by genetic defects affecting coagulation factors, fibrinogen, von Willebrand factor, or platelet function. Despite major advances in quantitative and functional laboratory assays, a substantial diagnostic gap remains, particularly in patients with mild or atypical ...
Anna R. Blankstein   +6 more
wiley   +1 more source

CLINICAL CASE: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN A CHILD

open access: yesЕвразийский Кардиологический Журнал, 2017
The article deals with a rare clinical case of chronic thromboembolic pulmonary hypertension in children. This case demonstrates the difficulty of identifying of chronic thromboembolic pulmonary hypertension and masking it under the community-acquired ...
D. J. Sadykova   +5 more
doaj   +1 more source

Right Ventricular Fibrosis: A Pathophysiological Factor in Pulmonary Hypertension?

open access: yes, 2019
The role of right ventricular (RV) fibrosis in pulmonary hypertension (PH) remains a subject of ongoing discussion. Alterations of the collagen network of the extracellular matrix may help prevent ventricular dilatation in the pressure-overloaded RV.
Andersen, Stine   +3 more
core   +1 more source

Percutaneous Sclerotherapy for Giant Hepatic Haemangiomas: A New Paradigm in Australia

open access: yes
ANZ Journal of Surgery, EarlyView.
Warren Clements   +3 more
wiley   +1 more source

Real‐World Use of Emicizumab in Patients With Acquired Haemophilia A: An Interim Safety Analysis of a Large‐Scale Post‑Marketing Surveillance Study

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Acquired haemophilia A (AHA) is a rare autoimmune disorder where the development of autoantibodies to factor (F)VIII neutralise its function, leading to bleeding. Emicizumab has been approved for treating AHA in Japan. Aim This post‐marketing study was performed to primarily examine the use and safety of emicizumab, and indirectly
Midori Shima   +8 more
wiley   +1 more source

Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

open access: yes, 2022
BACKGROUND: The success of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) is usually evaluated by performing a right heart catheterisation (RHC).
Symersky, Petr   +29 more
core   +1 more source

Home - About - Disclaimer - Privacy